New §101 Landscape: Exploring the Latest Developments at the PTO and District Court Relative to Patent Eligibility

May 16, 2019 10:45am

Charlotte Jacobsen
Partner
Ropes & Gray (New York, NY)

Leon Lum
Intellectual Property Counsel, Legal & Corporate Affairs
Novo Nordisk Inc (Plainsboro, NJ)

Michael Rueckheim
Partner
Winston & Stawn

Moderator

George Johnston
Counsel
Gibbons P.C. (Newark, NJ) (Former Vice President & Chief Patent Counsel, Hoffman-LaRoche)

  • Analyzing the USPTO’s newly released guidance on §101 and understanding its repercussions for patentability
  • Examine the District Courts’ standard on §101 subject matter eligibility
  • Discover whether a more stringent test is being proposed
  • Exploring the patent eligibility standard for the life sciences industries
    • Exploring outcomes and certainties
  • Developing best practices in drafting patent claims to avoid unpatentable subject matter findings
  • Evaluate the interaction between current subject matter eligibility guidance and the Federal Circuit’s decision in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals, 887 F.3d 1117 (Fed. Circ. 2018)
  • Discover whether recent decisions are favoring towards the influence of natural derivative